STOCK TITAN

CTS Corporation 10-Q Filings

CTS NYSE

Every 10-Q that CTS Corporation (CTS) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow CTS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CTS filings page.

Rhea-AI Summary

CTS Corporation reported higher earnings for the quarter and six months ended June 30, 2026. Net sales were $144,780, up from $135,309 a year earlier, producing gross margin of $60,048. Quarterly net earnings were $19,164 versus $18,527, with diluted EPS of $0.66.

For the first half of 2026, net sales reached $284,010 and net earnings were $36,361, with diluted EPS of $1.26. Operating cash flow improved to $50,735, helping lift cash and cash equivalents to $107,536 while long‑term debt outstanding was $55,000 on a $300,000 credit facility.

CTS recorded remediation reserves of $16,468, including an updated $6,711 estimate for its share of a proposed $7,610 environmental settlement at the Asheville site. The company also repurchased 240,439 shares for $12,101 under its 2025 share repurchase program, leaving 28,567,018 shares outstanding.

In June 2026 CTS announced the promotion of Pratik Trivedi to President and Chief Executive Officer, effective July 6, 2026, with former CEO Kieran OSullivan becoming Executive Chair.

Rhea-AI Summary

CTS Corporation reported a strong first quarter of 2026 with higher sales and margins. Net sales were $139.2 million, up 10.7% from a year earlier, driven mainly by 17.5% growth in diversified end markets and 2.9% growth in transportation.

Net earnings rose to $17.2 million, an increase of 28.7%, and diluted earnings per share improved to $0.59 from $0.44. Gross margin expanded from 37.0% to 39.5% on a better sales mix and efficiency gains. Operating cash flow was $17.3 million, supporting $5.0 million of capital spending.

CTS ended the quarter with $90.9 million of cash and $62.5 million of long‑term debt under its $300 million revolving credit facility. The company repurchased 176,909 shares for about $8.6 million and recorded a $6.7 million accrual for its estimated share of an Asheville environmental settlement, bringing total remediation reserves to $16.4 million.

Rhea-AI Summary

CTS Corporation (NYSE: CTS) reported Q3 2025 results. Net sales were $142.97M, up from $132.38M a year ago, driven by Industrial ($37.10M vs $30.75M), Medical ($21.96M vs $18.02M), and Aerospace & Defense ($25.36M vs $20.59M), while Transportation softened ($58.55M vs $63.03M). Operating earnings were essentially flat at $20.94M. Net earnings were $13.69M vs $18.08M, with diluted EPS of $0.46 vs $0.59 as higher SG&A and R&D offset gross profit gains.

Year to date, sales reached $404.05M vs $388.30M and net earnings were $45.58M vs $43.91M (diluted EPS $1.52 vs $1.43). Cash provided by operations was $72.89M, ending cash was $110.30M, and long‑term debt was $90.70M (weighted average rate 5.56%). The company repurchased 399,500 shares for $16.74M in Q3 and $40.08M year to date, with approximately $21.34M remaining under its program. Remediation reserves increased to $15.90M; for the Asheville, NC matter, the company recorded a $5.97M loss estimate within an updated exposure range of $5.97M to $8.29M. Shares outstanding were 29,052,423 as of October 21, 2025.